TMC

Current Thesis

The US deep-sea critical-minerals narrative is in a second-leg re-acceleration off the $3.93 low, not a fresh mania. The 2025 parabola (+450.9% on the Trump offshore-minerals EO) already peaked at $11.35 and corrected ~65%; we are now buying a policy-driven recovery leg with two live drivers: (1) NOAA found TMC USA's seabed-mining application in FULL compliance on 2026-05-01 (after a March substantial-compliance finding), advancing the only US-permitting path under DSHMRA toward a final decision targeted for end of Q1 2027; and (2) the brand-new Metals Royalty Company (TMCR) arm bolted a near-term cash line onto a pre-revenue story — closing a $132.5M, 1% Mesabi Metallics iron-ore royalty on 2026-06-01 with first royalty revenue guided to H2 2026. This is a special-situation policy/reshoring play, not a 1–3 week earnings-momentum trade. Probe-to-medium sizing, not a fat pitch.

Bull Case

• NOAA full-compliance finding 2026-05-01 is the regulatory unlock: triggers Federal Register posting → draft EIS → public comment → final license/permit decision (guided end-Q1 2027). TMC is the only public pure-play with a live US application.
• Allseas commercial nodule deal targets 3.0M wet tonnes/year, commissioning Q4 2027 (disclosed Q1 call 2026-05-14) — converts a science project into a defined production roadmap.
• TMCR royalty pivot adds real cash: $132.5M Mesabi 1% royalty closed 2026-06-01, option to double to 2% by 2026-07-31, first revenue H2 2026 as Mesabi commissions. Diversifies away from the binary 2027 nodule timeline.
• Government tailwind is structural: US is ~100% import-reliant on Ni/Co/Mn; TMC is in the DoD Defense Industrial Base Consortium and has a $9M DPA Title III grant application live for domestic refining; congressional defense funding mandated a nodule-refining feasibility study.
• Anchor capital: Korea Zinc's $85.2M strategic investment (June 2025, 19.6M shares at $4.34 + 6.9M warrants) validates the refining/pCAM pathway and seats a world-class metals refiner as a top holder.
• Sell-side leaning bullish: HC Wainwright reiterated Buy, $11.75 PT on 2026-06-02; consensus Strong Buy, avg PT ~$11.00 (~+83% from [entry redacted]).
• Tape is turning up: +17.3% over 2 weeks, +31% over 30 days, +81.5% over 1yr; June 1 closed +5.12% to $6.36.

Bear Case

• Pre-revenue, cash-burning core: Q1 2026 (reported 2026-05-14) net loss $20.6M, EPS -$0.05, ~$164M liquidity (cash + facilities) as of 2026-03-31. Nodule revenue is years out (Q4 2027 commissioning at earliest).
• Dilution overhang is imminent: funding the additional 1% Mesabi royalty option requires raising capital before 2026-07-31 — a likely equity raise into a recovering tape. Serial dilution has been the TMC pattern.
• The real catalyst is far away: NOAA final decision end-Q1 2027. Near-term flow is process headlines (Federal Register, draft EIS), not a dated binary inside 30 days.
• Regulatory/legal tail risk: International Seabed Authority and NGO opposition to deep-sea mining is intense; environmental litigation or an injunction could freeze the narrative.
• Overhead supply: ~47% below the $11.35 52-wk high means trapped 2025 holders sell into strength between $6 and $11.
• Commodity sensitivity: the $23.6B project NPV (March 2026 slides) flexes hard with nickel/cobalt prices — a base-metals slump guts the headline economics.

Setup & Price Structure

• Price ~$6.00 (2026-06-04, -1.96% on day); prev close $6.12; June 1 +5.12% close $6.36. 52-wk range $3.93 – $11.35. Market cap $2.60B, ~433M shares out, beta 1.99.
• Structure: higher-low re-acceleration leg off the $3.93 low; price above the 5-day MA ($5.43). +17.3% 2wk / +31% 30d. Not stretched — sits mid-range, ~47% under the prior high with clear overhead supply.
• RSI: mixed reads ~60–66 daily (neutral-to-firm) — room before a blow-off; not in trim territory.
• Read: clean enough to probe on the re-accel, but no near-term dated catalyst and a live dilution event keep this from a max-size entry. Add aggressively only on a draft-EIS/Federal Register confirmation or a clean higher low that holds above ~$5.

Catalyst Calendar (next 30 days)

• ~June–July 2026 (process-driven, no fixed date): NOAA next steps post-full-compliance — Federal Register posting of the application, draft Environmental Impact Statement publication + public-comment window. Any dated announcement is a momentum trigger.
• 2026-07-31 (just outside 30d): deadline for TMCR to fund/close the additional 1% Mesabi royalty option → watch for a capital raise (dilution) that could land inside the window.
• H2 2026: Mesabi Metallics commissioning → TMCR first royalty revenue.
• ~Mid-August 2026 (est.): Q2 2026 earnings (Q1 printed 2026-05-14) — outside 30d, no blackout now.
• Q4 2027 / end-Q1 2027 (far-dated anchors): Allseas nodule-system commissioning; NOAA final license/permit decision (the true binary).

What Would Change Our Mind

• Bull-confirming (add): NOAA publishes draft EIS / Federal Register posting on schedule; DoD DPA Title III $9M grant awarded; new strategic investor or binding offtake; Mesabi 2nd-royalty option funded with minimal dilution.
• Invalidation (cut): weekly close below $5.00 (breaks the higher-low re-accel structure off $3.93); a large dilutive equity raise (>$100M / >15M shares) to fund the Mesabi option; NOAA stalling or rejecting the application at the EIS/Federal Register stage; an ISA/NGO injunction; a nickel/cobalt collapse undercutting the project NPV.

Correlation Notes

• High beta (1.99); trades as a critical-minerals / US-reshoring proxy alongside MP Materials (MP) and USA Rare Earth (USAR), and moves on policy/defense headlines (Trump offshore EO, DoD funding). Risk-on, small-cap-momentum correlated — fades fast in de-risking tape.
• Korea Zinc as anchor shareholder ties sentiment to refining/pCAM build-out news.
• The TMCR royalty arm partially decouples TMC from the multi-year nodule timeline by adding iron-ore-linked cash (H2 2026), so the two business lines can diverge on news.
• Sensitive to nickel / cobalt / manganese spot and to ISA international-regulation headlines independent of equity-market beta.

Notes

Not a near-term earnings binary — Q1 printed 2026-05-14, Q2 ~mid-Aug; no 3-day earnings blocker. Primary risk to monitor is dilution timing (Mesabi option, deadline 2026-07-31). Treat as Dominant-Narrative policy play with a long-dated (Q1 2027) binary embedded.